Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (120)

Latest Posts

About This Stock More About This Stock
Week In Review: Jiangsu Hansoh To Raise Up To $3 Billion In Hong Kong IPO
Article By: ChinaBio® Today
Saturday, September 8, 2018 4:22 PM EDT
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established.
In this article: GSK, LLY, BGNE, ZLAB, ROG, HCM, MRK
Read
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Article By: ChinaBio® Today
Saturday, July 28, 2018 4:14 PM EDT
Long Hill Capital of Beijing and Shanghai, focused the healthcare and consumer sectors, closed its second fund at $265 million. Long Hill said it "significantly exceeded” its funding target, showing the success of its thesis-investing strategy.
In this article: BMY, MRK, SNY, CELG, BGNE
Read
Merck (MRK) Q2 Earnings & Sales Top On Keytruda Strength
Article By: Zacks Investment Research
Friday, July 27, 2018 10:00 AM EDT
Merck & Co., Inc. MRK reported second-quarter 2018 adjusted earnings of $1.06 per share, which beat the Zacks Consensus Estimate of $1.03 by 2.9%. Earnings rose 5% year over year.
In this article: MRK Also: AZN, GSK, LLY
Read
Week In Review Ending July 22: How Trump's Policies Moved Stocks
Article By: The Fly
Sunday, July 22, 2018 9:13 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: CAU, BA, F, GM, HMC, MRK, NVS, PFE, SNY, TM, DDAIF, NSANY, RHHBY, VLKAY, GOOG, GOOGL, FCAU
Read
Biotechs Cruise Onto Green Screen: July Looks Good
Article By: Rod Raynovich
Thursday, July 19, 2018 12:16 PM EDT
Biotechs cruised through the choppy market of late June to rally with many mid-caps rolling up and major ETFs up creeping toward 2018 highs. However, with earnings reports coming up, we could expect some selling depending on top line growth.
In this article: FBT, MRK, NVS, ACAD, IBB, CELG, VRTX, XBI, NVCR, CRSP, AMGN, CTNI, JNJ
Read

PARTNER HEADLINES

Latest Tweets for $MRK

No tweets yet!

$MRK

OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments